Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 1/20 | 0.39 |
| ▸ | GABRD | O14764 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.39 |
| ▸ | GABRE | P78334 | 1/20 | 0.39 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.39 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.39 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.39 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 8/20 | 0.37 |
| ▸ | AR | P10275 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL717583 | 0.83 | PKN1 (0.50) | ALDH1A1LMNAPKN1PKN2RIPK1 | |
| SCHEMBL27424880 | 0.81 | PARP1 (0.38) | PARP1PKN1PKN2RIPK1 | |
| SCHEMBL10450919 | 0.80 | PARP1 (0.39) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL28405125 | 0.80 | PKN1 (0.35) | PARP1ALDH1A1PKN1PKN2RIPK1 | |
| SCHEMBL6395560 | 0.79 | TSHR (0.53) | PARP1ALDH1A1LMNA | |
| SCHEMBL8853708 | 0.78 | PBRM1 (0.40) | PARP1 | |
| SCHEMBL2188295 | 0.77 | PARP1 (0.39) | PARP1PKN1PKN2 | |
| SCHEMBL11086452 | 0.77 | PKN1 (0.34) | PARP1PKN1PKN2RIPK1 | |
| SCHEMBL3838769 | 0.77 | ALDH1A1 (0.54) | ADRA1AALDH1A1LMNA | |
| SCHEMBL4813379 | 0.76 | PARP1 (0.38) | PARP1PKN1PKN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090312557-A1 | PROCESS FOR THE PREPARATION OF EPSILON -ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2009-12-17 | — | — | US | claimed |
| EP-3087085-A1 | SYNTHESIS OF A MACROCYCLIC HCV NS3 INHIBITING TRIPEPTIDE | Gilead Sciences, Inc. (US) | 2016-11-02 | — | — | EP | disclosed |
| WO-2015100145-A1 | SYNTHESIS OF A MACROCYCLIC HCV NS3 INHIBITING TRIPEPTIDE | GILEAD SCIENCES, INC. (US) | 2015-07-02 | — | — | WO | disclosed |
| EP-2046733-B1 | PROCESS FOR THE PREPARATION OF EPSILON-ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES | ITALIANA SINT SPA (IT) | 2011-10-05 | — | — | EP | disclosed |
| EP-2046733-B1 | PROCESS FOR THE PREPARATION OF EPSILON-ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES | ITALIANA SINT SPA (IT) | 2011-10-05 | — | — | EP | disclosed |
| US-8026372-B2 | Process for the preparation of ε-alkoxycarbonyllysines and their analogues | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2011-09-27 | — | — | US | disclosed |
| US-8026372-B2 | Process for the preparation of ε-alkoxycarbonyllysines and their analogues | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2011-09-27 | — | — | US | disclosed |
| US-20090312557-A1 | PROCESS FOR THE PREPARATION OF EPSILON -ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2009-12-17 | — | — | US | disclosed |
| US-20090312557-A1 | PROCESS FOR THE PREPARATION OF EPSILON -ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2009-12-17 | — | — | US | disclosed |
| EP-2046733-A1 | PROCESS FOR THE PREPARATION OF EPSILON-ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2009-04-15 | — | — | EP | disclosed |
| EP-2046733-A1 | PROCESS FOR THE PREPARATION OF EPSILON-ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2009-04-15 | — | — | EP | disclosed |
| US-20080242685-A1 | Chemical Compounds | SMITHKLINE BEECHAM CORPORATION | 2008-10-02 | — | — | US | disclosed |
| EP-1940296-A2 | CHEMICAL COMPOUNDS | SmithKline Beecham Corporation (US) | 2008-07-09 | — | — | EP | disclosed |
| WO-2008014811-A8 | PROCESS FOR THE PREPARATION OF ε-ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES | ITALIANA SINT SPA (IT) | 2008-06-05 | — | — | WO | disclosed |
| WO-2008014811-A1 | PROCESS FOR THE PREPARATION OF ε-ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A (IT) | 2008-02-07 | — | — | WO | disclosed |
| WO-2008014811-A1 | PROCESS FOR THE PREPARATION OF ε-ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A (IT) | 2008-02-07 | — | — | WO | disclosed |
| WO-2007114848-A2 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2007-10-11 | — | — | WO | disclosed |
| WO-2005092882-A1 | 4-AMINO-5-HALOGENO-BENZAMIDE DERIVATIVES AS 5-HT4 RECEPTOR AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL, CNS, NEUROLOGICAL AND CARDIOVASCULAR DISORDERS | PFIZER JAPAN, INC. (JP) | 2005-10-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242685-A1 | Chemical Compounds | NFKBIA, IKBKG, NFKB2 | GABRP 3847/4885GABRD 3337/4885GABRA1 2708/4885 |
| US-20090312557-A1 | PROCESS FOR THE PREPARATION OF EPSILON -ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES | AADAT, ALKBH3, BCAT2 | GABRP 416/4885GABRD 70/4885GABRA1 176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.